Format
Sort by
Items per page

Send to

Choose Destination

Links from PubChem BioAssay

Items: 6

1.

Balsalazide: a novel 5-aminosalicylate prodrug for the treatment of active ulcerative colitis.

Wiggins JB, Rajapakse R.

Expert Opin Drug Metab Toxicol. 2009 Oct;5(10):1279-84. doi: 10.1517/17425250903206996. Review.

PMID:
19743890
2.
3.

Inhibition of soybean lipoxygenase by sulfasalazine and 5-aminosalicylic acid: a possible mode of action in ulcerative colitis.

Sircar JC, Schwender CF, Carethers ME.

Biochem Pharmacol. 1983 Jan 1;32(1):170-2. No abstract available.

PMID:
6131674
4.

Meclofenamate sodium is an inhibitor of both the 5-lipoxygenase and cyclooxygenase pathways of the arachidonic acid cascade in vitro.

Boctor AM, Eickholt M, Pugsley TA.

Prostaglandins Leukot Med. 1986 Aug;23(2-3):229-38.

PMID:
3020588
5.

Inhibition of 5-lipoxygenase pathway of arachidonic acid metabolism in human neutrophils by sulfasalazine and 5-aminosalicylic acid.

Nielsen OH, Bukhave K, Elmgreen J, Ahnfelt-Rønne I.

Dig Dis Sci. 1987 Jun;32(6):577-82.

PMID:
2882965
6.

5-Lipoxygenase inhibitors for the treatment of inflammatory bowel disease.

Rask-Madsen J, Bukhave K, Laursen LS, Lauritsen K.

Agents Actions. 1992;Spec No:C37-46. Review.

PMID:
1359745

Supplemental Content

Support Center